Thesis title: The allure of biomedical innovation: what influences drive, and shape, doctors' use of innovative treatments?
Supervisors: Ian Kerridge, Wendy Lipworth
Thesis abstract:
Since the early 20th century, there has been remarkable technological progress in medicine. Biomedical innovations – including new medical and surgical procedures, equipment, devices and processes, as well as pharmacological agents, have transformed medical practice.
Although the term “innovation” is widely used in medicine, and fostering innovation is considered by many to be essential for the continuation of medical and technological advancement, there is a distinct lack of consensus regarding how to define biomedical innovation, and how to best assess the value of novel drugs, devices and procedures. This is problematic, as there is significant variation in the clinical benefits conferred by various innovative medical treatments, and many of these treatments are significantly more expensive than traditional therapeutics. Doctors’ use of innovative treatments, therefore, warrants ethical consideration.
It is now recognised in practice and in law that doctors’ behaviours are shaped by a wide range of non-financial and financial interests—an interest in patient care, being the most obvious. To date, however, there has been little systematic research into the interests that drive, and shape, doctors’ use of innovative treatments in clinical practice. Furthermore, the limited evidence available is often constrained to one specific medical setting – for example, the drivers of doctors’ use of innovative medicines in end of life cancer care.
In order to address this evidence gap, this empirical bioethics project will explore the non-financial and financial influences driving doctors’ use of innovative treatments. The project will be based around four case studies, including innovation in surgery, stem cell treatment, assisted reproductive technology and cancer care. Semi-structured interviews will be conducted with key stakeholders (including doctors, regulators and policymakers), critically appraised and integrated with ethical theory, in order to inform the development of clinical practice guidelines and health policy regulations to encourage “responsible” clinical innovation in Australia.
Book Chapters
Journals
2024
2023
2022
2021
2020
2019
2018